APPlife Digital Solutions (ALDS) 10-Q 14 May 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2021	May 13, 2021
Document And Entity Information
Entity Registrant Name	APPlife Digital Solutions Inc
Entity Central Index Key	0001755101
Document Type	10-Q
Document Period End Date	Mar. 31, 2021
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Is Entity's Reporting Status Current?	Yes
Is Entity Emerging Growth Company?	true
Elected Not To Use the Extended Transition Period	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		134,689,404
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Entity File Number	000-54524
Entity Tax Identification Number	30-0678378
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	50 California St, #1500
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94111
City Area Code	415
Local Phone Number	439-5260

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2021	Jun. 30, 2020
Current assets
Cash	$ 433,945	$ 85,707
Prepaid expenses	137,278	388,426
Inventories	43,373	43,675
Other current assets	0	7,574
Total assets	614,596	525,382
Current liabilities
Accounts payable and accrued expenses	186,323	113,469
Common stock payable	54,999	80,000
Notes payable - current, net	148,701	522,283
Derivative liabilities	44,690	248,173
Due to officer	6,428	6,428
Total current liabilities	441,141	970,353
Notes payable - noncurrent, net	1,171,745	0
Deferred revenue	0	0
Total liabilities	1,612,886	970,353
Stockholders' deficit
Common stock, $0.001 par value, 500,000,000 shares authorized; 134,488,320 and 127,037,531 shares issued and outstanding as of March 31, 2021 and June 30, 2020, respectively	134,488	127,037
Additional paid-in capital	7,309,193	5,037,883
Accumulated (deficit)	(8,441,971)	(5,609,891)
Total stockholders' deficit	(998,290)	(444,971)
Total liabilities and stockholders' deficit	$ 614,596	$ 525,382

UNAUDITED CONDENSED CONSOLIDA_2

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2021	Jun. 30, 2020
Stockholders' (deficit) equity
Common Stock, par or stated value	$ 0.001	$ 0.001
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, shares issued	134,488,320	127,037,531
Common Stock, shares outstanding	134,488,320	127,037,531

UNAUDITED CONDENSED CONSOLIDA_3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue	$ 1,410	$ 1,312	$ 3,716	$ 1,458
Cost of goods sold	(3,973)	(83)	(5,467)	(222)
Gross profit (loss)	(2,563)	1,229	(1,751)	1,236
Operating expenses	757,671	512,952	2,414,312	2,105,283
Impairment of investment	0	0	0	500,055
Loss from equity method investment	0	0	0	14,638
Total operating expenses	757,671	512,952	2,414,312	2,619,976
Loss from operations	(760,234)	(511,723)	(2,416,063)	(2,618,740)
Other income (expense)
Interest expense	(79,241)	(45,215)	(453,048)	(113,375)
Loss on extension of notes payable	0	0	(41,214)	0
Change in fair value of derivative liability	75,733	(32,690)	78,245	(50,323)
Net loss before provision for income taxes	(763,742)	(589,628)	(2,832,080)	(2,782,438)
Provision for income taxes	0	0	0	0
Net Loss	$ (763,742)	$ (589,628)	$ (2,832,080)	$ (2,782,438)
Basic and diluted loss per share	$ 0.02	$ 0.02	$ 0.07	$ 0.09
Average number of common shares outstanding - basic and diluted	41,437,015	33,699,619	39,780,656	31,924,158

UNAUDITED CONDENSED CONSOLIDA_4

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Stockholders' Equity Attributable to Parent, Beginning Balance at Jun. 30, 2019	$ 119,059	$ 1,796,170	$ (1,661,636)	$ 253,593
Shares, Outstanding, Beginning Balance at Jun. 30, 2019	119,059,674
Common stock issued for cash, value	$ 1,000	99,000		100,000
Common stock issued for cash, shares	1,000,000
Stock compensation, value		1,054,691		1,054,691
Stock compensation, shares
Common stock issued for services, value	$ 4,528	731,923		736,451
Common stock issued for services, shares	4,527,857
Eliminate derivative liability upon repayment of debt		13,585		13,585
Conversion of notes payable to equity, value	$ 200	6,794		6,994
Conversion of notes payable to equity, shares	200,000
Net Loss			(2,782,438)	(2,782,438)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2020	$ 124,787	3,702,163	(4,444,074)	(617,124)
Shares, Outstanding, Ending Balance at Mar. 31, 2020	124,787,531
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2019	$ 123,537	3,226,849	(3,854,446)	(504,060)
Shares, Outstanding, Beginning Balance at Dec. 31, 2019	123,537,531
Stock compensation, value	$ 1,000	99,000		100,000
Stock compensation, shares	1,000,000
Common stock issued for services, value		351,564		351,564
Common stock issued for services, shares
Eliminate derivative liability upon repayment of debt
Conversion of notes payable to equity, value	$ 250	24,750		25,000
Conversion of notes payable to equity, shares	250,000
Net Loss			(589,628)	(589,628)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2020	$ 124,787	3,702,163	(4,444,074)	(617,124)
Shares, Outstanding, Ending Balance at Mar. 31, 2020	124,787,531
Stockholders' Equity Attributable to Parent, Beginning Balance at Jun. 30, 2020	$ 127,037	5,037,883	(5,609,891)	(444,971)
Shares, Outstanding, Beginning Balance at Jun. 30, 2020	127,037,531
Common stock issued for cash, value	$ 1,200	118,800		120,000
Common stock issued for cash, shares	1,200,000
Stock compensation, value		1,120,878		1,120,878
Stock compensation, shares
Common stock issued for services, value	$ 5,230	460,148		465,378
Common stock issued for services, shares	5,229,030
Issuance of common stock payable, value	$ 140	25,096		25,236
Issuance of common stock payable, shares	140,199
Shares issued for prepayment penalty, value	$ 277	45,237		45,514
Shares issued for prepayment penalty, shares	277,012
Payment of notes payable with issuance of common stock, value	$ 604	74,366		74,970
Payment of notes payable with issuance of common stock, shares	604,548
Loss on extension of notes payable		41,214		41,214
Eliminate derivative liability upon repayment of debt		125,238		125,238
Equity component of issuance of convertible notes		260,333		260,333
Net Loss			(2,832,080)	(2,832,080)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2021	$ 134,488	7,309,193	(8,441,971)	(998,290)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	134,488,320
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	$ 133,960	6,780,958	(7,678,229)	(763,311)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	133,960,606
Stock compensation, value		417,753		417,753
Stock compensation, shares
Common stock issued for services, value	$ 528	70,482		71,010
Common stock issued for services, shares	527,714
Equity component of issuance of convertible notes		40,000		40,000
Net Loss			(763,742)	(763,742)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2021	$ 134,488	$ 7,309,193	$ (8,441,971)	$ (998,290)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	134,488,320

UNAUDITED STATEMENTS OF CASH FL

UNAUDITED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,832,080)	$ (2,782,438)
Adjustment to reconcile change in net loss to net cash used in operating activities:
Amortization	231,785	73,085
Issuance of common stock for services	465,378	737,451
Shares issued for prepayment penalty	45,514	0
Loss on extension of notes payable	41,214	0
Stock compensation expense	1,120,878	1,054,691
Impairment of investment	0	500,055
Loss from equity method investment	0	14,638
Change in fair value of derivative liability	(78,245)	50,323
Changes in operating assets and liabilities:
Accounts Receivable	7,574	(7,574)
Prepaid expenses and other current assets	251,148	(62,522)
Inventories	302	(37,455)
Common stock payable	235	(25,417)
Accounts payable and accrued expenses	111,535	(6,578)
Net cash (used )in operating activities	(634,762)	(491,741)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable	1,048,000	520,000
Proceeds from issuance of common stock	120,000	0
Payment on notes payable	(185,000)	(9,506)
Payment on amounts due to Smartrade	0	(59,898)
Payment on amounts due to officer	0	(3,152)
Proceeds from issuance of common stock	0	99,000
Net cash provided from financing activities	983,000	546,444
Net increase in cash and cash equivalents	348,238	54,703
Cash and cash equivalents, beginning of period	85,707	65,654
Cash and cash equivalents, end of period	433,945	120,357
Supplemental disclosure of cash flow information:
Cash paid for interest	16,153	0
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Conversion of notes payable to equity	0	5,119
Eliminate derivative liability upon repayment of debt	125,238	13,585
Issuance of common stock payable	25,236	0
Equity component of issuance of convertible notes	260,333	0
Payment of notes payable with issuance of common stock	$ 74,970	$ 0

Note 1 - Organization And Summa

Note 1 - Organization And Summary Of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Note 1 - Organization And Summary Of Significant Accounting Policies	Note 1 – Organization and Summary of Significant Accounting Policies Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. The Company’s mission is using digital technology to create APPs and websites that make life, business and living easier, more efficient and just smarter. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s subscription service that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. OFFICE HOP, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. OFFICE HOP is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms. Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The current pandemic known as COVID-19 as described in Note 5, creates additional uncertainty. The accompanying consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern. Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for the interim financial information and with instructions to Form 10-Q and Article 10 of Regulation S-X. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. All intercompany transactions have been eliminated in consolidation. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2020, as filed with the SEC on September 25, 2020. Operating results for the nine months ended March 31, 2021 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the fiscal year ending June 30, 2021. Cash and Cash Equivalents For the purpose of the statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less. Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of March 31, 2021. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California. Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates. Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, ”Revenue from Contracts with Customers, ” Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. There were no potentially dilutive securities for the period ended March 31, 2021 and year ended June 30, 2020. Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures · Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. · Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. · Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s consolidated financial statements for cash, accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these consolidated financial instruments. Derivative Liability FASB ASC 815, Derivatives and Hedging requires all derivatives to be recorded on the consolidated balance sheet at fair value. As of March 31, 2021, we used the Black-Scholes-Merton (BSM) model to estimate the fair value of the conversion feature of the convertible note. Key assumptions of the BSM model include the market price of our stock, the conversion price of the debt, applicable volatility rates, risk-free interest rates and the instrument’s remaining term. These assumptions require significant management judgment. In addition, changes in any of these variables during a period can result in material changes in the fair value (and resultant gains or losses) of this derivative instrument. Leases In February 2016, the Financial Accounting Standards Board (the “FASB”) established ASC Topic 842, “Leases”, by issuing Accounting Standards Update (“ASU”) No. 2016-02, which requires lessees to now recognize operating leases on the balance sheet and disclose key information about leasing arrangements. ASC Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. Lessor accounting under the new standard is substantially unchanged. Additional qualitative and quantitative disclosures are also required. Adoption of this standard did not result in any material changes to the financial statements. Inventories Inventory, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of March 31, 2021, the Company had inventories of approximately $43,373. The Company has no allowance for inventory reserves. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material on the Company’s financial statements and financial statement disclosures.

Note 2 - Notes Payable

Note 2 - Notes Payable	9 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Note 2 - Notes Payable	Note 2 – Notes Payable In March 2018, the Company issued notes that carry an 8% annual interest rate and mature through December 31, 2019. In December 2019, $5,119 of principal was converted into Company common stock and payments were made of $11,381. In March 2020, the note was exchanged for a convertible promissory note that accrues interest at 10% per annum and matures on March 11, 2021. The principal balance of the new note is $77,235 as of March 31, 2021. On July 3, 2019, the Company issued a $250,000 convertible promissory note (the “July 2019 Note”) to a lender (the “Lender”). According to the terms the Lender funded the July 2019 Note as follows: $100,000 upon the execution of the Note, $50,000 on August 1, 2019, $50,000 on September 1, 2019, and the remaining $50,000 on October 1, 2019. The outstanding principal balance of the Note shall bear interest at the rate of twelve percent (12%) per annum. The balance of the July 2019 Note was $250,000 on March 31, 2021 and matures July 3, 2021. On October 1, 2019, the Company entered into a securities purchase agreement with an investor (“Investor”) to issue up to $220,000 of convertible promissory notes tranches of $55,000 at the Investor’s discretion. Through June 30, 2020, two tranches were issued, and the balance of these promissory notes was $110,000. These notes accrue interest at 10% per annum. On July 20, 2020, these two notes were extended through September 30, 2020 and October 30, 2020, respectively. As an inducement to extend the notes, the Company promised to issue 277,012 shares of common stock valued at $40,000 to the Investor. On September 29, 2020, the Company paid $81,675 towards the first tranche which includes principal of $55,000, prepayment penalty of $21,175 and accrued interest of $5,500. Additionally, the Company issued 153,410 shares of common stock valued at $0.20 per share, or $30,682, to the Investor. On October 29, 2020, the Company paid $81,553 toward the final tranche of the notes issued on October 1, 2019, which consists of principal of $55,000, interest of $5,410 and a prepayment penalty of $21,143. The Company also issued 123,602 shares to the Investor valued at $14,832 in conjunction with the prior extension of this note. On November 22, 2019, Company issued a $170,000 convertible promissory note (the “November 2019 Note”) to the Lender that accrues interest at 12% per annum. The July and November Notes contain embedded derivatives, see Note 7. On April 7, 2020, the Company entered into a securities purchase agreement with an investor pursuant to which the Company sold a convertible note (“April 2020 Note”) bearing 8% interest in the principal amount of $111,290. On October 27, 2020, the Company entered into an agreement to pay off the April 2020 Note with $75,000, 416,295 shares of common stock at $0.1328 per share, or $55,484 and 188,253 shares, valued at $0.1328 per share, or $25,000. During the nine months ended March 31, 2021, the Company paid off the note with $75,000 and issued the 604,548 shares to the investor. On July 14, 2020 and October 21, 2020, the Company sold convertible notes bearing 12% interest in the principal amounts of $340,000 and $348,000, respectively. Subject to certain ownership limitations, the notes will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion price of $0.144. The embedded conversion features of these notes were valued at $85,000 and $135,333, respectively, and is amortized over the life of the notes. On January 12, 2021, the Company sold convertible notes bearing 12% interest on the principal amount of $360,000, respectively. The principal amount was agreed to be paid in two tranches of $180,000 each, received on February19, 2021 and March 08, 2021. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $0.144. The embedded conversion features of this note were valued at $35,500 and $7,500 for each tranche received and are amortized over the life of the note. Amount Balance of notes payable, net of discount on June 30, 2020 $ 522,283 Issuances of debt, net of discount 787,667 Amortization of debt discount 231,786 Payments on notes payable (185,000) Payment of notes payable with issuance of common stock (36,290) Balance of notes payable, net of discount as of March 31, 2021 $ 1,320,446

Note 3 - Related Party Transact

Note 3 - Related Party Transactions	9 Months Ended
	Mar. 31, 2021
Related Party Transactions [Abstract]
Note 3 - Related Party Transactions	Note 3 – Related Party Transactions Due to Officer During the year ending June 30, 2018, the Company received advances from its officer to pay for certain operating expenses. The balance due to the officer as of March 31, 2021 and June 30, 2020 was $6,428. There are no definitive repayment terms, and no interest is accruing on these advances.

Note 4 - Concentrations

Note 4 - Concentrations	9 Months Ended
	Mar. 31, 2021
Risks and Uncertainties [Abstract]
Note 4 - Concentrations	Note 4 – Concentrations Cash Concentration The Company maintains its cash and cash equivalents at a financial institution which may, at times, exceed federally insured limits. As of March 31, 2021, the Company’s cash balance exceeded the FDIC insurance limit by $183,945. The Company has not experienced any losses in such accounts.

Note 5 - Commitments And Contin

Note 5 - Commitments And Contingencies	9 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Note 5 - Commitments And Contingencies	Note 5 – Commitments and Contingencies Legal Matters From time to time the Company may be involved in certain legal actions and claims arising in the ordinary course of business. The Company was not a party to any specific legal actions or claims as of March 31, 2021. Agreements On April 4, 2018, the Company entered into an agreement with GHS, where the Company is entitled, at its sole discretion, to request equity investments of up to $5 million over twenty-four months following an effective registration of the underlying shares. On April 22, 2020, the Company, entered into a letter agreement with Maxim Group, LLC (“Maxim”) for Maxim to provide general financial advisory, investment banking, and digital marketing services for the Company. The fees paid to Maxim in exchange for the services under the agreement are a combination of cash and common stock. On May 7, 2020, the Company issued 2,250,000 shares of common stock to Maxim. On July 21, 2020, the Company, entered into a letter agreement (the “Agreement”) with Carter, Terry & Company (“CT&Co”) for CT&Co to act as the Company’s exclusive financial advisor and placement agent, on a best efforts basis. Under the terms of the Agreement, CT&Co will be the Company’s exclusive financial advisor for an initial period of thirty (30) days and then reverting to a non-exclusive financial advisor for the next twelve (12) months, with an option to extend for an additional six (6) months. Both the Company and CT&Co may cancel the Agreement at any time upon written notice to the other party. Within five (5) days of execution of the Agreement, the Company shall issue 500,000 shares of its restricted common stock to CT&Co. As additional consideration, the Company shall pay CT&Co a success fee of ten percent (10%) of the amount of any equity or hybrid equity capital raised up to $1,000,000, eight percent (8%) of the amount of any equity or hybrid equity capital raised up to $5,000,000, and six percent (6%) of the amount of any equity or hybrid equity capital raised over $5,000,000. In connection with the compensation set forth above, the Company shall also issue to CT&Co restricted shares of its common stock equal to four percent (4%) of the capital raised divided by the last reported closing price of the Company’s common stock on the date of the close. Common Stock Payable As of March 31, 2021, and June 30, 2020, the Company owes $54,999 and $80,000 worth of common stock to vendors for services rendered, respectively. Other Risks On March 12, 2020, the World Health Organization declared COVID-19 to be a pandemic, and the COVID-19 pandemic has resulted in significant financial market volatility and uncertainty. A continuation or worsening of the levels of market disruption and volatility seen in the recent past could have an adverse effect on our ability to access capital, on our business, results of operations and financial condition, and on the market price of our common shares. While we did not incur significant disruptions from the COVID-19 pandemic during the quarter ended March 31, 2021, this situation could have an impact on our future business and results of operations in 2021 that may be material but cannot be reasonably estimated at this time due to numerous uncertainties.

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit	9 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Note 6 - Shareholders' Deficit	Note 6 – Stockholders’ Deficit As of March 31, 2021, and June 30, 2020, there were 134,488,320 and 127,037,531 shares of common stock issued and outstanding, respectively. On October 22, 2020, the Company entered into a securities purchase agreement with an investor where the Company issued 1,200,000 shares of common stock valued at $0.10 per share, or $120,000. Common stock issued for services and stock options During the nine months ended March 31, 2021 and 2020, the Company issued 5,229,030 and 4,527,857 shares of common stock to third parties for services valued at $465,378 and $736,450, respectively, with prices between $0.13 and $0.24 per share. For the nine months ended March 31, 2021 and 2020, the Company recognized stock compensation expense on outstanding restricted stock awards of $1,161,208 and 1,054,688, respectively. Between January 28, 2021 and March 16, 2021, the Company issued 527,714 shares of common stock valued at $0.14 per share, or $71,009 to consultants for services rendered. During the third quarter of 2021, the Company granted 1,094,959 stock options, in the aggregate, to its board members. The options vest pro-rata over the member’s term, have exercise prices between $0.14 and $0.17 and expire in five years from the date of grant. Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – December 31, 2020 - $ - - Granted 1,094,959 0.16 5 Forfeited - - - Exercised - - - Outstanding – March 31, 2021 1,094,959 $ 0.16 5 Shares issued for prepayment penalty On September 29, 2020, the Company paid $81,675 towards one of its outstanding notes, which includes principal of $55,000, prepayment penalty of $21,175 and accrued interest of $5,500. As an inducement to pay off the note early, the Company issued 153,410 shares of common stock valued at $0.20 per share, or $30,682 to the Investor (see Note 2). On October 29, 2020, the Company paid $81,553 toward the final tranche of the notes issued on October 1, 2019, which consists of principal of $55,000, interest of $5,410 and a prepayment penalty of $21,143. The Company also issued 123,602 shares to the creditor valued at $14,832 in conjunction with the prior extension of this note. Equity component of issuance of convertible notes On July 14, 2020 and October 21, 2020, the Company sold convertible notes bearing 12% interest in the principal amounts of $340,000 and $348,000, respectively. Subject to certain ownership limitations, the notes will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion price of $0.144. The embedded conversion features of these notes were valued at $85,000 and $135,333, respectively, and is amortized over the life of the notes. On January 12, 2021, the Company sold convertible notes bearing 12% interest on the principal amount of $360,000, respectively (see Note 2). The embedded conversion features of this note was valued at $40,000 and is amortized over the life of the note.

Note 7 - Derivative Liability

Note 7 - Derivative Liability	9 Months Ended
	Mar. 31, 2021
Disclosure Text Block [Abstract]
Note 7 - Derivative Liability	Note 7 – Derivative Liability The Company issued debts that consist of the issuance of convertible notes with variable conversion provisions. The conversion terms of the convertible notes are variable based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock issuable upon conversion of the promissory note is indeterminate. Pursuant to ASC 815-15 Embedded Derivatives, the fair values of the variable conversion option and shares to be issued were recorded as derivative liabilities on the issuance date and revalued at each reporting period. A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the three months ended March 31, 2021 is as follows: Quarter Ended March 31, 2021 Stock price $ 0.17 Exercise price $ 0.22 – 0.37 Contractual term (in years) 0.25 – 0.64 Volatility (annual) 206 % Risk-free rate 0.03% - 0.07 % The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuations. Financial Liabilities Measured at Fair Value on a Recurring Basis Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability – warrants and derivative liabilities: Fair value measured at March 31, 2021 Quoted prices in Significant other Significant active markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) March 31, 2021 Derivative liability $ — $ — $ 44,690 $ 44,690 Total $ — $ — $ 44,690 $ 44,690 Fair Value measured at June 30, 2020 Quoted prices in Significant other Significant active markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2020 Derivative liability $ - $ - $ 248,173 $ 248,173 Total $ - $ - $ 248,173 $ 248,173 The fair value accounting standards define fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an asset or liability. Fair value measurements are rated on a three-tier hierarchy as follows: ● Level 1 inputs: Quoted prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2 inputs: Inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and ● Level 3 inputs: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions. There were no transfers between Level 1, 2 or 3 during the period ended March 31, 2021. During the nine months ended March 31, 2021 and 2020, the Company recorded a gain of $78,245 and a loss of $50,323, respectively, from the change in fair value of derivative liability. The following table presents changes in Level 3 liabilities measured at fair value for the period ended March 31, 2021: Derivative Liability Balance – June 30, 2020 $ 248,173 Changes due to redemptions (125,238) Change in fair value of derivative liability (78,245) Balance – March 31, 2021 $ 44,690 The balance of the derivative liability at March 31, 2021 and June 30, 2020 was $44,690 and $248,173, respectively.

Note 8 - Subsequent Events

Note 8 - Subsequent Events	9 Months Ended
	Mar. 31, 2021
Subsequent Events [Abstract]
Note 8 - Subsequent Events	Note 8 – Subsequent Events The Company has evaluated subsequent events after the balance sheet date through the date of this filing and found that there were no material events to disclose during this time.

Note 1 - Organization And Sum_2

Note 1 - Organization And Summary Of Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Organization	Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. The Company’s mission is using digital technology to create APPs and websites that make life, business and living easier, more efficient and just smarter. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s subscription service that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. OFFICE HOP, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. OFFICE HOP is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms.
Going Concern	Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The current pandemic known as COVID-19 as described in Note 5, creates additional uncertainty. The accompanying consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern.
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for the interim financial information and with instructions to Form 10-Q and Article 10 of Regulation S-X. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. All intercompany transactions have been eliminated in consolidation. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2020, as filed with the SEC on September 25, 2020. Operating results for the nine months ended March 31, 2021 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the fiscal year ending June 30, 2021. Cash and Cash Equivalents For the purpose of the statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less.
Income Taxes	Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of March 31, 2021. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California.
Use of Estimates	Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates.
Revenue Recognition	Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, ”Revenue from Contracts with Customers, ”
Stock Based Compensation	Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.
Net Loss per Share	Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. There were no potentially dilutive securities for the period ended March 31, 2021 and year ended June 30, 2020.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures · Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. · Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. · Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s consolidated financial statements for cash, accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these consolidated financial instruments.
Derivative Liability	Derivative Liability FASB ASC 815, Derivatives and Hedging requires all derivatives to be recorded on the consolidated balance sheet at fair value. As of March 31, 2021, we used the Black-Scholes-Merton (BSM) model to estimate the fair value of the conversion feature of the convertible note. Key assumptions of the BSM model include the market price of our stock, the conversion price of the debt, applicable volatility rates, risk-free interest rates and the instrument’s remaining term. These assumptions require significant management judgment. In addition, changes in any of these variables during a period can result in material changes in the fair value (and resultant gains or losses) of this derivative instrument.
Leases	Leases In February 2016, the Financial Accounting Standards Board (the “FASB”) established ASC Topic 842, “Leases”, by issuing Accounting Standards Update (“ASU”) No. 2016-02, which requires lessees to now recognize operating leases on the balance sheet and disclose key information about leasing arrangements. ASC Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. Lessor accounting under the new standard is substantially unchanged. Additional qualitative and quantitative disclosures are also required. Adoption of this standard did not result in any material changes to the financial statements.
Inventories	Inventories Inventory, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of March 31, 2021, the Company had inventories of approximately $43,373. The Company has no allowance for inventory reserves.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material on the Company’s financial statements and financial statement disclosures.

Note 2 - Notes Payable (Tables)

Note 2 - Notes Payable (Tables)	9 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Schedule of note payable	The embedded conversion features of this note were valued at $35,500 and $7,500 for each tranche received and are amortized over the life of the note. Amount Balance of notes payable, net of discount on June 30, 2020 $ 522,283 Issuances of debt, net of discount 787,667 Amortization of debt discount 231,786 Payments on notes payable (185,000) Payment of notes payable with issuance of common stock (36,290) Balance of notes payable, net of discount as of March 31, 2021 $ 1,320,446

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit (Tables)	9 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Schedule of Stock Option Activity	During the third quarter of 2021, the Company granted 1,094,959 stock options, in the aggregate, to its board members. The options vest pro-rata over the member’s term, have exercise prices between $0.14 and $0.17 and expire in five years from the date of grant. Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – December 31, 2020 - $ - - Granted 1,094,959 0.16 5 Forfeited - - - Exercised - - - Outstanding – March 31, 2021 1,094,959 $ 0.16 5

Note 7 - Derivative Liability (

Note 7 - Derivative Liability (Tables)	9 Months Ended
	Mar. 31, 2021
Disclosure Text Block [Abstract]
Schedule of valuation methodology	A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the three months ended March 31, 2021 is as follows: Quarter Ended March 31, 2021 Stock price $ 0.17 Exercise price $ 0.22 – 0.37 Contractual term (in years) 0.25 – 0.64 Volatility (annual) 206 % Risk-free rate 0.03% - 0.07 %
Fair value, liabilities measured on recurring basis	Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability – warrants and derivative liabilities: Fair value measured at March 31, 2021 Quoted prices in Significant other Significant active markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) March 31, 2021 Derivative liability $ — $ — $ 44,690 $ 44,690 Total $ — $ — $ 44,690 $ 44,690 Fair Value measured at June 30, 2020 Quoted prices in Significant other Significant active markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2020 Derivative liability $ - $ - $ 248,173 $ 248,173 Total $ - $ - $ 248,173 $ 248,173
Schedule of changes in Level 3 liabilities	The following table presents changes in Level 3 liabilities measured at fair value for the period ended March 31, 2021: Derivative Liability Balance – June 30, 2020 $ 248,173 Changes due to redemptions (125,238) Change in fair value of derivative liability (78,245) Balance – March 31, 2021 $ 44,690

Note 1 - Organization And Sum_3

Note 1 - Organization And Summary Of Significant Accounting Policies (Details) - USD ($)	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Jun. 30, 2020
Accounting Policies [Abstract]
Interest and penalties	$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	0
Inventories	$ 43,373	$ 43,675
Inventory reserves	$ 0

Note 2 - Notes Payable (Details

Note 2 - Notes Payable (Details) - USD ($)	Oct. 01, 2019	Jul. 03, 2019	Oct. 29, 2020	Oct. 27, 2020	Nov. 22, 2019	Mar. 31, 2021	Mar. 31, 2021	Mar. 31, 2020	Feb. 19, 2021	Jan. 12, 2021	Oct. 21, 2020	Jul. 14, 2020	Jun. 30, 2020	Apr. 07, 2020
Notes payable, net						$ 148,701	$ 148,701						$ 522,283
Conversion of notes payable to equity, value							74,970
Payments on notes payable							$ 185,000	$ 9,506
Lender
Debt Instrument, interest rate											12.00%	12.00%
Conversion price											$ 0.144	$ 0.144
Investor | Securities Purchase Agreement
Debt Instrument, Interest Rate During Period	10.00%
Notes payable, net													$ 110,000
Conversion of notes payable to equity, value	$ 40,000		$ 14,832
Conversion of notes payable to equity, shares			123,602
Shares reserved for future issuance	277,012
Payments on notes payable			$ 81,553
Payment, description	On September 29, 2020, the Company paid $81,675 towards the first tranche which includes principal of $55,000, prepayment penalty of $21,175 and accrued interest of $5,500. Additionally, the Company issued 153,410 shares of common stock valued at $0.20 per share, or $30,682, to the Investor
Proceeds from convertible promissory notes	$ 220,000
Convertible promissory notes description	Convertible promissory notes in monthly tranches of $55,000 at the Investor’s discretion
Investor | Securities Purchase Agreement | Principal
Payments on notes payable			55,000
Investor | Securities Purchase Agreement | Interest
Payments on notes payable			5,410
Investor | Securities Purchase Agreement | Penalty
Payments on notes payable			$ 21,143
March 2018 notes
Debt Instrument, Interest Rate During Period							8.00%
Debt Instrument, Maturity Date							Dec. 31, 2019
Conversion of notes payable to equity, value							$ 5,119
Payments on notes payable							$ 11,381
March 2020 note
Debt Instrument, Maturity Date							Mar. 11, 2021
Debt Instrument, interest rate						10.00%	10.00%
Notes payable, net						$ 77,235	$ 77,235
July 2019 Note | Lender
Debt Instrument, Interest Rate During Period		12.00%
Debt Instrument, Maturity Date		Jul. 3, 2021
Principal amount		$ 250,000
Notes payable, net						250,000	$ 250,000
November 2019 Note | Lender
Debt Instrument, Interest Rate During Period					12.00%
Principal amount					$ 170,000
April 2020 Note | Investor
Debt Instrument, interest rate														8.00%
Principal amount														$ 111,290
Conversion of notes payable to equity, value				$ 75,000		$ 75,000
Conversion of notes payable to equity, shares				416,295		604,548
Conversion price				$ 0.1328
April 2020 Note 1 | Investor
Conversion of notes payable to equity, value				$ 55,484
Conversion of notes payable to equity, shares				188,253
April 2020 Note 2 | Investor
Conversion of notes payable to equity, value				$ 25,000
July 2020 Note | Investor
Debt Instrument, interest rate											12.00%	12.00%
Principal amount											$ 348,000	$ 340,000
Conversion price											$ 0.144	$ 0.144
Embedded conversion feature											$ 135,333	$ 85,000
January 2021 Note | Investor
Debt Instrument, interest rate										12.00%
Principal amount										$ 360,000
January 2021 Note | Tranches 1
Debt Instrument, interest rate									12.00%
Principal amount									$ 180,000
Conversion price									$ 0.144
Embedded conversion feature									$ 35,500
January 2021 Note | Tranches 2
Principal amount									180,000
Embedded conversion feature									$ 7,500

Note 2 - Notes Payable _ Schedu

Note 2 - Notes Payable : Schedule of note payable (Details) - USD ($)	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Debt Disclosure [Abstract]
Balance of notes payable, net of discount at begging	$ 522,283
Issuances of debt, net of discount	787,667
Amortization of debt discount	231,786
Payments on notes payable	(185,000)	$ (9,506)
Payment of notes payable with issuance of common stock	(36,290)
Balance of notes payable, net of discount at end	$ 1,320,446

Note 3 - Related Party Transa_2

Note 3 - Related Party Transactions (Details) - USD ($)	Mar. 31, 2021	Jun. 30, 2020
Related Party Transactions [Abstract]
Due to officer	$ 6,428	$ 6,428

Note 4 - Concentrations (Detail

Note 4 - Concentrations (Details)	9 Months Ended
	Mar. 31, 2021USD ($)
Risks and Uncertainties [Abstract]
Increase FDIC limit	$ 183,945

Note 5 - Commitments And Cont_2

Note 5 - Commitments And Contingencies (Details) - USD ($)	May 07, 2020	Apr. 04, 2018	Jul. 21, 2020	Mar. 31, 2021	Jun. 30, 2020
Debt Instrument, Convertible, Type of Equity Security		Equity investments of up to $5 million over twenty-four months following an effective registration of the underlying shares.
Common stock payable				$ 54,999	$ 80,000
Letter Agreement [Member]
Agreement, description			Within five (5) days of execution of the Agreement, the Company shall issue 500,000 shares of its restricted common stock to CT&Co. As additional consideration, the Company shall pay CT&Co a success fee of ten percent (10%) of the amount of any equity or hybrid equity capital raised up to $1,000,000, eight percent (8%) of the amount of any equity or hybrid equity capital raised up to $5,000,000, and six percent (6%) of the amount of any equity or hybrid equity capital raised over $5,000,000.
Maxim
Common stock shares issued for services, shares	2,250,000

Note 6 - Stockholders' Defici_2

Note 6 - Stockholders' Deficit (Details) - USD ($)	Jul. 14, 2020	Oct. 29, 2020	Oct. 22, 2020	Oct. 21, 2020	Sep. 29, 2020	Mar. 16, 2021	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Common Stock, shares issued							134,488,320		134,488,320		127,037,531
Common Stock, shares outstanding							134,488,320		134,488,320		127,037,531
Share price					$ 0.20		$ 0.17		$ 0.17
Common stock issued for services, value							$ 71,010	$ 351,564	$ 465,378	$ 736,451
Share based expense									1,120,878	1,054,691
Payment of related party debt									0	$ 59,898
Issuance of Common Stock Payable, value									$ 25,236
Note 1
Payment of related party debt					$ 81,675
Shares issued upon prepayment penalty, shares					153,410
Shares issued upon prepayment penalty, value					$ 30,682
Note 1 | Principal
Payment of related party debt					55,000
Note 1 | Penalty
Payment of related party debt					21,175
Note 1 | Interest
Payment of related party debt					$ 5,500
Note 2
Payment of related party debt		$ 81,553
Shares issued upon prepayment penalty, shares		123,602
Shares issued upon prepayment penalty, value		$ 14,832
Note 2 | Principal
Payment of related party debt		55,000
Note 2 | Penalty
Payment of related party debt		21,143
Note 2 | Interest
Payment of related party debt		$ 5,410
Third parties
Share price							$ 0.13	$ 0.24	$ 0.13	$ 0.24
Common stock issued for services, shares									5,229,030	4,527,857
Common stock issued for services, value									$ 465,378	$ 736,450
Issuance of Common Stock Payable, shares									1,094,959	0
Issuance of Common Stock Payable, value									$ 23,169	$ 0
Chief Executive Officer [Member]
Share based expense									$ 1,161,208	$ 1,054,688
Consultants
Share price						$ 0.14
Common stock issued for services, shares						527,714
Common stock issued for services, value						$ 71,009
Investor
Shares issued for acquisition, shares			1,200,000
Shares issued for acquisition, value			$ 120,000
Share price			$ 0.10
Lender
Conversion price	$ 0.144			$ 0.144
Embedded conversion fair value	$ 85,000			$ 135,333
Debt Instrument, interest rate	12.00%			12.00%

Note 6 - Stockholders' Deficit_

Note 6 - Stockholders' Deficit: Schedule of Stock Option Activity (Details)	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Equity [Abstract]
Outstanding, beginning | shares
Options granted | shares	1,094,959
Option Forfeited | shares
Options exercised | shares
Options Outstanding, Ending balance | shares	1,094,959
Weighted average exercise price beginning balance | $ / shares
Weighted Average Exercise Price, granted | $ / shares	0.16
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Exercise Price, exercised | $ / shares
Weighed average exercise price ending balance | $ / shares	$ 0.16
Weighted Average Remaining Life, granted	5 years
Weighted Average Remaining Life, outstanding	5 years

Note 6 - Stockholders' Defici_3

Note 6 - Stockholders' Deficit: Assumptions (Details) - $ / shares	3 Months Ended	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2021	Sep. 29, 2020
Stock price	$ 0.17	$ 0.17	$ 0.20
Volatility (annual)		206.00%
Minimum [Member]
Exercise price	0.22	$ 0.22
Contractual term (in years)		2 months 30 days
Risk-free rate		0.03%
Maximum [Member]
Exercise price	$ 0.37	$ 0.37
Contractual term (in years)		7 months 21 days
Risk-free rate		0.07%
Stock options [Member]
Contractual term (in years)	3 years
Volatility (annual)	206.40%
Risk-free rate	0.22%
Stock options [Member] | Minimum [Member]
Stock price	$ 0.16	$ 0.16
Exercise price	0.16	0.16
Stock options [Member] | Maximum [Member]
Stock price	0.17	0.17
Exercise price	$ 0.17	$ 0.17

Note 7 - Derivative Liability_2

Note 7 - Derivative Liability (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Disclosure Text Block [Abstract]
Change in fair value of derivative liability	$ 75,733	$ (32,690)	$ 78,245	$ (50,323)
Derivative liability	$ 44,690		$ 44,690		$ 248,173

Note 7 - Derivative Liability _

Note 7 - Derivative Liability : Schedule of valuation methodology (Details) - $ / shares	9 Months Ended
	Mar. 31, 2021	Sep. 29, 2020
Stock price	$ 0.17	$ 0.20
Volatility (annual)	206.00%
Minimum [Member]
Exercise price	$ 0.22
Contractual term (in years)	2 months 30 days
Risk-free rate	0.03%
Maximum [Member]
Exercise price	$ 0.37
Contractual term (in years)	7 months 21 days
Risk-free rate	0.07%

Note 7 - Derivative Liability_3

Note 7 - Derivative Liability : Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($)	Mar. 31, 2021	Jun. 30, 2020
Derivative liability	$ 44,690	$ 248,173
Fair Value, Inputs, Level 1 [Member]
Derivative liability	0	0
Fair Value, Inputs, Level 2 [Member]
Derivative liability	0	0
Fair Value, Inputs, Level 3 [Member]
Derivative liability	$ 44,690	$ 248,173

Note 7 - Derivative Liability_4

Note 7 - Derivative Liability : Schedule of changes in Level 3 liabilities (Details)	9 Months Ended
	Mar. 31, 2021USD ($)
Disclosure Text Block [Abstract]
Balance at beginning	$ 248,173
Changes due to redemptions	(125,238)
Change in fair value of derivative liability	(78,245)
Balance at end	$ 44,690